Drug profile · INN
peramivir hydrate
RAPIACTA
peramivir hydrate (RAPIACTA) is a neuraminidase inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — peramivir hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
peramivir hydrate (RAPIACTA) is a neuraminidase inhibitor.
Key facts
INN peramivir hydrate
Brand RAPIACTA
Mechanism Neuraminidase inhibitor
Target Neuraminidase
Mechanism of action
Neuraminidase inhibitor
Primary target: Neuraminidase
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is peramivir hydrate?
peramivir hydrate (RAPIACTA) is a neuraminidase inhibitor.
What is the brand name for peramivir hydrate?
RAPIACTA is a marketed brand name for peramivir hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.